Actively Recruiting
Ways of Retaining the Inframammary Fold in Implant-based Breast Surgery
Led by Branch Office of "Hadassah Medical Ltd" · Updated on 2025-04-17
100
Participants Needed
1
Research Sites
204 weeks
Total Duration
On this page
Sponsors
B
Branch Office of "Hadassah Medical Ltd"
Lead Sponsor
F
Federal Research Clinical Center of Federal Medical & Biological Agency, Russia
Collaborating Sponsor
AI-Summary
What this Trial Is About
There is currently no consensus on the "gold standard" for Implant-based Breast reconstruction. In the United States, more than half of all breast reconstructions are performed using acellular dermal matrix (ADM). However, based on the findings of literature and systematic reviews, it can be cautiously said that synthetic meshes cause fewer complications with comparable aesthetic results and low cost. In our study, we propose using polytetrafluoroethylene (PTFE) mesh in implant-based breast reconstruction. This material has previously proven itself in cardiovascular, maxillofacial and neurosurgery, hernioplasty and as a suture material. Allogeneic dura mater, which has demonstrated comparable results in breast reconstruction with the literature, will be used as a comparison. The purpose of this study is to evaluate the efficacy and safety of a porous, non-biodegradable, synthetic polytetrafluoroethylene mesh for implant-based breast reconstruction in patients diagnosed with breast cancer. An allogeneic dura mater technique will be used as a control. Patients eligible for this study are classified according to the National Comprehensive Cancer Network (NCCN) guidelines as having stage 0-2 breast cancer. The primary questions this study aims to answer are: * What are the rates of major and minor complications associated with these techniques. Major complications will be defined as complications leading to reoperation. * How effective are PTFE mesh and dura in maintaining the inframammary fold and implant projection after breast reconstruction? * What is the patient satisfaction rate with the surgical results? Patients will be randomly assigned to the study but will know which technique will be used in their particular case. Patients included in this study will undergo subcutaneous mastectomy or skin-sparing mastectomy using standard techniques with simultaneous implantation using PTFE mesh or allogeneic dura mater graft. In our opinion, the mesh and graft will stabilize the projections of the inframammary fold and breast implant. After the surgery, all minor and major complications will be recorded for 6 months. For this, both physical examination and radiological diagnostic methods will be used, including breast ultrasound and MRI with contrast. Revision surgeries will be performed if necessary. Projections of the inframammary fold and breast implant will also be measured in order to determine the effectiveness of the compared techniques. Patients will be asked to complete the BREAST-Q Version 2.0© Reconstruction Module questionnaire to determine satisfaction with the surgical outcome. The results of the study will help the professional community to determine the most effective method of Implant-based Breast reconstruction and will be published in peer-reviewed scientific journals.
CONDITIONS
Official Title
Ways of Retaining the Inframammary Fold in Implant-based Breast Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- White women
- Breast cancer stage 0-II
- Indications for breast reconstruction
- Consent to participate in the study and photographic documentation
You will not qualify if you...
- Non-white women
- Breast cancer stage III-IV
- Tubular breast
- Mental and cognitive health disorders
- Failure to comply with postoperative recommendations such as premature physical activity, not wearing compression underwear, missing scheduled visits, or refusing photo documentation
- Patient refusal to participate in the study at any stage
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Branch of Hadassah Medical LTD
Moscow, Skolkovo Innovation Center, Russia, 121205
Actively Recruiting
Research Team
A
Artem Mishin, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here